Lataa...
Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
Osteosarcoma is the frequent pediatric bone cancer where pediatric osteosarcoma incidences are more than 10% within the population. Most of the patients with osteosarcoma fall within the age of 15–30 years. Therefore, in this research, we examined the anticancer effect of Rhaponticin against the hum...
Tallennettuna:
| Julkaisussa: | Saudi J Biol Sci |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8241634/ https://ncbi.nlm.nih.gov/pubmed/34220214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjbs.2021.05.006 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|